SEARCH LISTED COMPANY

Any AUS or NZ company

BROWSE

Browse Australian delisted companies

0-9 A B C D E F G H I J K L M N O P Q R S T U V W X Y Z

Browse terminated Australian managed funds

0-9 A B C D E F G H I J K L M N O P Q R S T U V W X Y Z
SEARCH PRIVATE COMPANY

SEARCH FUNDS

Find any Australian or New Zealand company or fund (dead or alive) by using SEARCH above or go directly to the site:

SIMAVITA LIMITED (SVA)

Click here for free access to this company's:
ASX, Legal & CGT Status

SHARE PRICES

(updated at weekends)

Former (or subsequent) names

 

Shareholder links

Our website ranking of SVA: rating 4
(4 out of 5)
COMPANY WEBSITE:

 

REGISTRY:
Computershare, Yarra Falls, 452 Johnston Street, Abbotsford VIC 3067
Tel : +61 (0)3 9415 4000 or 1300 850 505 (within Australia)
Fax : +61 3 9473 2500
RegistryWebsite RegistryEmail

Company details

ISIN: AU000000SVA1
Address: 60-66 Hanover Street, FITZROY, VIC, AUSTRALIA, 3065
Tel:  (02) 8405 6300 Fax: 

Date first listed: 20/02/2014
Company Secretary: Peta Jurd
Sector: Health Care Equipment & Services
Industry Group: XHJ
Activities: Medical device company

delisted from the close of trading on Monday, 22 February 2021, pursuant to Listing rule 17.11.

22/02/2021

we understand the company delisted because potential partners stated a preference for it to be non-listed, improved access to capital, best interest of CDI holders, prospects for growth, low value attributed to company, illiquidity, administrative costs and large number of unmarketable parcels - the company bought back almost 1.1m shares at A$0.0185 per CDI in a capital reduction offer, payment being made on 28 January 2021

22/02/2021

Under Listing Rule 17.6, any entity (if not already suspended) that has not paid its annual listing fees by close of business on Friday, 19 February 2021 will have its securities suspended from official quotation before the commencement of trading on Monday, 22 February 2021. The company has not paid the second instalment of its annual listing fees in respect of the year ending 30 June 2021 but the securities are already suspended from official quotation.

22/02/2021

The securities of Simavita Limited will be suspended from quotation at the close of trading today, Thursday, 18 February 2021, in accordance with Listing Rule 17.2, pending the removal from the Official List on Monday, 22 February 2021.

18/02/2021

The securities of Simavita Limited will be reinstated to Official Quotation immediately following the lodgement of its Statutory Accounts for the year ended 30 June 2020.

08/10/2020

Simavita reports full year audited financial results

08/10/2020

The company has experienced an unexpected delay in finalising its audited financial statements for the year ended 30 June 2020. The directors anticipate that the audited accounts will be finalised shortly.

01/10/2020

The securities of the company will be suspended from Official Quotation in accordance with Listing Rule 17.5 from the commencement of trading today, 1 October 2020, following their failure to lodge the relevant periodic report by the due date.

01/10/2020

The securities of Simavita Limited will be reinstated to Official Quotation as from the commencement of trading on Friday, 19 July 2019 following lodgement of its Appendix 4D Half Year Financial Report for the year ended 31 December 2018.

18/07/2019

Simavita Releases HFY19 Appendix 4D and Interim Financials

17/07/2019

The company announces the results of the Special General Meeting of the company's shareholders which was held at 10:00 am today in Sydney. All 6 resolutions that were put out before the meeting were carried by way of a poll.

14/06/2019

Simavita releases materials for Special General Meeting for $3.075m secured notes financing. The meeting will be held at 10.00 am (AEST) on 24 June 2019 at the following address: The offices of K&L Gates Level 31, 1 O'Connell Street Sydney. New South Wales. 2000. Australia. The company has now been granted a waiver by the ASX from seeking member approval under ASX Listing Rule 10.1.

31/05/2019

The company had secured funding commitments in aggregate of over $3 million from professional and sophisticated investors to assist it in the commercialiastion of its unique platform technology AlertPLUS focused on the USD64bn diaper industry.

10/05/2019

Simavita releases Appendix 4C for quarter 31 March 2019

30/04/2019

The company's securities will be suspended from official quotation following failure to lodge the relevant periodic report by the duee date.

01/03/2019

The securities of Simavita Limited will be reinstated to official quotation as from the commencement of trading today, Thursday, 4 October 2018 following announcements regarding the completion of a placement and lodgement of its Statutory Accounts for the year ended 30 June 2018.

04/10/2018

The company had completed a $2,975,000 financing. This was achieved by a private placement for $1.975 million and a further $1 million by way of a convertible note (subject to approval from shareholders at the 2018 Annual General Meeting). Proceeds will be used by the Company for working capital and key commercialization activities specifically focused on major markets in North America and Europe.

03/10/2018

Simavita reports full year financial results. Total comprehensive loss after tax for the full year ended June 30, 2018 was $4.94m million, a decrease of 36% on the prior corresponding period. Total revenues for the full year were $1.10m a decrease of 41% on the prior corresponding period. Whilst revenues have decreased, expenses have decreased by a greater amount resulting in a reduction in the loss incurred by the Company. Revenues are also impacted by the expected reduction in the R&D tax incentive for the 2018 financial year due to reduced R&D expenditure incurred. The Company has developed and patented, a hyper low cost platform technology. AlertPLUSâ„¢ is focused upon a rapidly growing USD64bn per year, adult and infant diaper industry. The Company continues to progress partnership discussions with several major international diaper manufacturers based in North America and Europe. The first of these agreements was signed in August a European based global diaper manufacturer. Cash balance recorded at the end of the period was $1.36m million.

03/10/2018

The securities of Simavita Limited will be suspended from quotation immediately under Listing Rule 17.2, at the request of SVA, pending the release of an announcement regarding a proposed placement.

27/09/2018

The securities of Simavita Limited will be reinstated to quotation immediately, following the release of an announcement by the Company.

27/04/2016

The company today announced that the Company, supported by its major shareholders, has completed a review of its Board, operations; executive management and working capital. With immediate effect, changes to the Board have been implemented, new funding facilities have been made available and a change to the future strategy of the Company has commenced. The Company has issued secured notes which has raised AUD$3,063,000 to assist in meeting the Company's immediate obligations and to provide a clear runway for a major restructuring of the Company's operations and implementation of a new strategy.

27/04/2016

The securities of Simavita Limited (the "Company") will be suspended from official quotation immediately at the request of the Company, pending the release of an announcement regarding a potential capital raise and the possible changes to the composition to the Company's board of directors.

19/04/2016

listed entity carried for record purposes only

20/02/2014

ASX Announcements (courtesy of ASX)

 

 

Click here for free access to this company's:
ASX, Legal & CGT Status

Your comments

Please read our Terms before viewing comments.

 

Company Updates

Post your comments here

Please read our Terms before posting comments.
OMISSIONS
    You can post a comment here about this company

    Please click in the "I'm not a robot" box. If an image appears, enter the word/figures you see in the image.

    loading Posting your comments. Please wait...

    Directors' on-market share transactions (last 5)

     

    Click here for the last 20 transactions all companies

    Directors & Executives (current)

    NAMETITLEDATE OF APPT
    Michael SpoonerExecutive Chairman27/04/2016
    Gary PaceNon Exec Director27/04/2016
    John McBainDirector26/11/2019
    Alan FisherDirector23/07/2019

    Date of first appointment, title may have changed.

    Directors & Executives (former)

    NAMETITLEDATE OF APPOINTMENTDATE OF RESIGNATION
    Warren BinghamDirector15/12/201511/12/2018
    Craig HollandIndependent Director14/11/201406/05/2016
    Michael BrownChairman07/01/201527/04/2016
    Philippa LewisCEO27/04/2016
    Ari BergmanNon Exec Director29/02/2016
    Damien HaakmanDirector29/02/2016
    Tom HowittCFO01/12/201315/01/2016
    Peter CookChairman20/11/201312/09/2014
    Colin ChristieCFO19/11/201228/02/2014

    Date of first appointment, title may have changed.